MDxHealth (NasdaqCM:MDXH) Q3 2026 Earnings call November 12, 2026 04:30 PM ET Company ParticipantsJohn Fraunces - Managing DirectorMichael McGarrity - CEORon Kalfus - Interim CFOConference Call ParticipantsThomas Flaten - AnalystDan Brennan - AnalystMark Massaro - AnalystBill Bonello - AnalystOperatorPlease note this call is being recorded, and we are standing by if you should need any assistance. It is now my pleasure to turn the meeting over to John Fraunces with LifeSci Advisors. Please go ahead.John Fra ...

MDxHealth (NasdaqCM:MDXH) Q3 2026 Earnings call November 12, 2026 04:30 PM ET Speaker0Please note this call is being recorded, and we are standing by if you should need any assistance. It is now my pleasure to turn the meeting over to John Fraunces with LifeSci Advisors. Please go ahead.Speaker1Before we begin, I would like to remind everyone that the company will make forward-looking statements during today's call. Whether in prepared remarks or during the Q&A session, these forward-looking statements are ...

Conference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, Calif. – November 12, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced its financial results for the third quarter ended September 30, 2026. Michael K. McGarrity, CEO of mdxhealth, commented: “As we communicated in our October preliminary update, our third quarter results reflect a temporary disruption in our commercial execution due to accel ...